WallStSmart

Cintas Corporation (CTAS)vsDolby Laboratories (DLB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cintas Corporation generates 708% more annual revenue ($11.03B vs $1.36B). DLB leads profitability with a 17.8% profit margin vs 17.6%. DLB appears more attractively valued with a PEG of 2.08. DLB earns a higher WallStSmart Score of 61/100 (C+).

CTAS

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 9.0Value: 2.7Quality: 7.5
Piotroski: 6/9Altman Z: 4.29

DLB

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 7.5Value: 6.7Quality: 8.0
Piotroski: 3/9Altman Z: 4.85
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTASSignificantly Overvalued (-38.5%)

Margin of Safety

-38.5%

Fair Value

$144.61

Current Price

$179.85

$35.24 premium

UndervaluedFair: $144.61Overvalued
DLBUndervalued (+35.2%)

Margin of Safety

+35.2%

Fair Value

$106.61

Current Price

$53.78

$52.83 discount

UndervaluedFair: $106.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTAS4 strengths · Avg: 9.3/10
Return on EquityProfitability
40.5%10/10

Every $100 of equity generates 40 in profit

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Market CapQuality
$69.91B9/10

Large-cap with strong market position

Operating MarginProfitability
23.2%8/10

Strong operational efficiency at 23.2%

DLB4 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.8510/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Operating MarginProfitability
29.1%8/10

Strong operational efficiency at 29.1%

Areas to Watch

CTAS3 concerns · Avg: 3.3/10
P/E RatioValuation
36.9x4/10

Premium valuation, high expectations priced in

Price/BookValuation
15.0x4/10

Trading at 15.0x book value

PEG RatioValuation
2.762/10

Expensive relative to growth rate

DLB2 concerns · Avg: 3.5/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CTAS

The strongest argument for CTAS centers on Return on Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 17.6% and operating margin at 23.2%.

Bull Case : DLB

The strongest argument for DLB centers on Debt/Equity, Altman Z-Score, Price/Book. Profitability is solid with margins at 17.8% and operating margin at 29.1%.

Bear Case : CTAS

The primary concerns for CTAS are P/E Ratio, Price/Book, PEG Ratio.

Bear Case : DLB

The primary concerns for DLB are PEG Ratio, Piotroski F-Score.

Key Dynamics to Monitor

CTAS carries more volatility with a beta of 0.96 — expect wider price swings.

CTAS is growing revenue faster at 8.9% — sustainability is the question.

CTAS generates stronger free cash flow (531M), providing more financial flexibility.

Monitor SPECIALTY BUSINESS SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DLB scores higher overall (61/100 vs 58/100), backed by strong 17.8% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cintas Corporation

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Cintas Corporation is an American corporation headquartered in Cincinnati, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses.

Dolby Laboratories

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

Want to dig deeper into these stocks?